The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
2201 METHARAN N BETAMETHASONE SODIUM PHOSPHATE BP 0.1 % W/V, NEOMYCINE SULFATE BP 0.5 %W/V,THIOMERSAL BP 0.005 % W/V SOLUTION BOTTLE EYE: SHORT TERM TREATMENT OF STEROID RESPONSIVE INFLAMMATORY, EAR: OTITIS EXTERNA OR OTHER STEROID RESPONSIVE, NOSE: STEROID RESPONSIVE INFLAMMATORY CONDITIONS WHERE PROPHYLACTIC ANTIBIOTIC TREATMENT IS ALSO REQUIRED NULL POUNSAB PHARMA CO.,LTD BRAWN LABORATORIES LIMITED INDIA CERTIFICATE RELEASED 04 I 4672/19 06-DEC-2022 05-DEC-2025 View
2202 MFLOX MOXIFLOXACIN HYDROCHLORIDE BP EQ.TO MOXIFLOXACIN 0.5 % W/V EYE DROPS BOTTLE TOPICAL TREATMENT OF PURULENT BACTERIAL CONJUNCTIVITIS, CAUSED BY MOXIFLOXACIN SUSCEPTIBLE STRAINS, NULL POUNSAB PHARMA CO.,LTD AUROLAB INDIA CERTIFICATE RELEASED 10 I 5610/23 09-Oct-2023 08-Oct-2026 View
2203 MFLOX-DM MOXIFLOXACIN HYDROCHLORIDE BP EQ.TO MOXIFLOXACIN 0.5 % W/V, DEXAMETHASONE SODIUM PHOSPHATE BP 0.1 % W/V EYE DROPS BOTTLE PREVENTION AND TREATMENT OF INFLAMMATION AND PREVENTION OF INFECTION ASSOCIATED WITH CATARACT SURGERY IN ADULTS AND CHILDREN AGED 2 YEARS AND OLDER NULL POUNSAB PHARMA CO.,LTD AUROLAB INDIA CERTIFICATE RELEASED 10 I 5611/23 09-Oct-2023 08-Oct-2026 View
2204 MIZOLE CLOTRIMAZOLE 500 MG TABLET BLISTERPACK FOR THE TREATMENT OF VAGINAL CANDIDIASIS, TRICHOMONIASIS, CHRONIC RECURRENT MYCOSIS, VAGINITIS DUE TO FUNGI, INFECTIONS LEUCORRHOEA, VAGINAL MYCOSIS DURING PREGNANCY, PROPHYLACTIC AGAINST NEONATAL THRUSH AS PRENATAL THERAPY, DYSPAREUNIA. NULL POUNSAB PHARMA CO.,LTD PHARMIX LABORATORIES (PVT ) LTD PAKISTAN CERTIFICATE RELEASED 09 I 4184/16 02-NOV-2023 01-NOV-2026 View
2205 MORCET TABLETS 10 MG ESCITALOPRAM OXALATE 12.78 MG EQ.TO ESCITALOPRAM 10 MG TABLET ALU-PVC BLISTER INDICATED FOR SYMPTOMATIC RELIEF OF MAJOR DEPRESSIVE DISORDER, ANXIETY CAUSING CLINICALLY SIGNIFICANT DISTRESS IN PATIENTS WITH GENERALISED ANXIETY DISORDER, OBSESSIVE-COMPULSIVE DISORDER NULL POUNSAB PHARMA CO.,LTD THE SEARLE COMPANY LIMITED PAKISTAN CERTIFICATE RELEASED 05 I 5509/23 09-MAY-2023 08-MAY-2026 View
2206 MORCET TABLETS 20 MG ESCITALOPRAM OXLATE 25.54 MG EQ.TO ESCITALOPRAM 20 MG TABLETS ALU-PVC BLISTER FOR SYMPTOMATIC RELIEF OF MAJOR DEPRESSIVE, ANXIETY CAUSING CLINICALLY SIGNIFICANT DISTRESS IN PATIENTS WITH GENERALIZED ANXIETY DISORDER, OBSESSIVE-COMPULSIVE DISORDER NULL POUNSAB PHARMA CO.,LTD THE SEARLE COMPANY LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 5765/24 27-Jun-2024 26-Jun-2027 View
2207 MYOSOFT THIOCOLCHICOSIDE 4 MG CAPSULE BLISTERPACK TREATMENT OF THE PAINFUL MUSCULAR CONTRACTURES IN ACUTE AND CHRONIC RHEUMATOLOGIC AND ORTHOPEDIC DISEASES (LUMBAGO, SCIATICA, CERVICOBRACHIAL PAIN. NULL POUNSAB PHARMA CO.,LTD PHARMIX LABORATORIES (PVT ) LTD PAKISTAN CERTIFICATE RELEASED 09 I 4205/16 02-NOV-2023 01-NOV-2026 View
2208 OMIPIN OMEPRAZOLE SODIUM BP EQ.TO OMEPRAZOLE 40 MG POWDER FOR SOLUTION FOR INJECTION VIAL FOR SHORT TERM TREATMENT OF DUODENAL ULCER, GASTRIC ULCER, REFLUX OESOPHAGITIS, ZOLLINGER-ELLISON SYDROME WHEN ORAL THERAPY IS REGARDED INAPPROPRIATE OR CONTRA-INDICATED, FOR UP TO 5 DAYS NULL POUNSAB PHARMA CO.,LTD BRAWN LABORATORIES LIMITED INDIA CERTIFICATE RELEASED 04 I 4674/19 06-DEC-2022 05-DEC-2025 View
2209 ONLEZOLE FLUCONAZOLE USP 150 MG CAPSULE BLISTERPACK INDICATED FOR THE TREATMENT AND PROPHYLAXIS OF FUNGAL INFECTIONS WHERE OTHER ANTIFUNGALS HAVE FAILED OR ARE NOT TOLERATED NULL POUNSAB PHARMA CO.,LTD PHARMIX LABORATORIES (PVT ) LTD PAKISTAN CERTIFICATE RELEASED 09 I 4193/16 02-NOV-2023 01-NOV-2026 View
2210 PAAR 250 PARACETAMOL BP 250 MG/ 5 ML ORAL SUSPENSION BOTTLE FOR THE TREATMENT OF MILD TO MODERATE PAIN, INCLUDING HEADACHE, MIGRAINE, NEURALGIA, TOOTHACHE, SORE THROAT, ACHES AND PAINS, FOR THE REDUCTION OF FEVER AND TO BE USED AS AN ADJUNCTIVE TREATMENT TO RELIEVE SYMPTOMS OF COLD AND FLU. NULL POUNSAB PHARMA CO.,LTD BAROQUE PHARMACEUTICALS PVT LTD. INDIA CERTIFICATE RELEASED 09 I 4204/16 07-JUL-2025 06-JUL-2030 View